UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: November 20, 2015
Accession Number:
Submission Type:
CIK: 0000949858
Company Name: ONCOGENEX PHARMACEUTICALS, INC.
File Number: 333-207670